Articles from: ALNY (Alnylam Pharmaceuticals Inc) (MSN Money)
 |
|
|
|
|
| Next Page
| |
| Alnylam to Webcast Presentation at ThinkEquity's 2nd Annual Health Care Con (more) | 2011 05 20 |
|
| Alnylam's ALN-VSP Abstract Published by American Society of Clinical Oncolo (more) | 2011 05 19 |
|
| Regulus Therapeutics Expands Executive Team with Recent Appointments (more) | 2011 05 18 |
|
|
|
| Alnylam to Webcast Presentation at 2011 Bank of America Merrill Lynch Healt (more) | 2011 05 04 |
|
|
| Alnylam Pharmaceuticals Reports First Quarter 2011 Financial Results (more) | 2011 05 02 |
|
| ASCO 2011: Opportunities for Biotech Investor Success and Failure (more) | 2011 05 02 |
|
| Regulus Therapeutics and Collaborators Present New Results from Preclinical (more) | 2011 04 28 |
|
| Alnylam to Webcast Conference Call Discussing First Quarter 2011 Financial (more) | 2011 04 27 |
|
| Precision NanoSystems and Alnylam Form New Delivery Collaboration (more) | 2011 04 19 |
|
| Regulus Therapeutics Appoints Neil W. Gibson, Ph.D., Chief Scientific Offic (more) | 2011 04 18 |
|
| Regulus Therapeutics and UC San Diego to Collaborate on Angiogenic Disease (more) | 2011 04 14 |
|
|
| AlCana Technologies, The University of British Columbia, and Alnylam Extend (more) | 2011 04 07 |
|
| Alnylam Files Answer and Counterclaim Related to Tekmira Lawsuit (more) | 2011 04 06 |
|
|
|
|
|
| Alnylam to Webcast Presentation at 10th Annual Needham Healthcare Conferenc (more) | 2011 03 30 |
|
| Regulus Therapeutics Receives Exclusive License for Intellectual Property t (more) | 2011 03 30 |
|
| Alnylam Achieves Key Technology Transfer Objective in its Takeda Alliance; (more) | 2011 03 28 |
|
|
| Regulus Therapeutics Appoints Lars Karlsson, M.D., Ph.D., VP of Immunology (more) | 2011 03 21 |
|
|
|
|
|
| Alnylam Pharmaceuticals Reaches Settlement in Litigation Regarding Tuschl P (more) | 2011 03 15 |
|
| Alnylam to Webcast Presentations at Upcoming Investor Conferences (more) | 2011 03 08 |
|
|
|
| Alnylam to Webcast Presentation at 31st Annual Cowen and Company Health Car (more) | 2011 03 02 |
|
| Regulus Therapeutics Strengthens Strategic Alliance Team Responsible for Ma (more) | 2011 02 28 |
|
|
|
|
|
| Alnylam Sees Progress in Biotherapeutics, but No Impact to Our Fair Value (more) | 2011 02 22 |
|
| Alnylam, Caterpillar, Clearwire, EOG, Monsanto, Rogers: U.S. Equity Movers (more) | 2011 02 18 |
|
|
|
| Alnylam Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results (more) | 2011 02 17 |
|
| Alnylam to Webcast Conference Call Discussing Fourth Quarter and 2010 Finan (more) | 2011 02 10 |
|
| Regulus Therapeutics to Present Multiple Platform and Pipeline Advancements (more) | 2011 02 10 |
|
| Alnylam to Webcast Presentation at the 13th Annual BIO CEO & Investor Confe (more) | 2011 02 09 |
|
| Alnylam Receives Positive Opinion for Orphan Drug Designation from European (more) | 2011 02 03 |
|
|
| Next Page
| |